Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia
Authors:
- 1 December 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (11) , 1215-1219
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)The American Journal of Cardiology, 1993
- Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.Circulation, 1989
- Sex difference in antithrombotic effect of aspirin.Stroke, 1989
- Sex-related differences in the effects of aspirin on the interaction of platelets with subendotheliumThrombosis Research, 1986
- Systemic availability of acetylsalicylic acid in normal men and women and its effect on in vitro platelet aggregabilityEuropean Journal of Clinical Pharmacology, 1983
- A Randomized, Controlled Trial of Aspirin in Persons Recovered From Myocardial InfarctionJAMA, 1980
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978